Important notice

Unavailability of certain services in drug insurance

Some services related to prescription drug insurance coverage are currently unavailable due to technical issues. These issues affect covered pharmacy services. We are working to resolve the situation as quickly as possible. Thank you for your understanding.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

56 results found.

Example of search result explained

Hyrimoz (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,2 mL) DIN : 2542315
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2542323
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2542358
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 2505258
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2492164

Hadlima PushTouch (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2533480
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2473100

Hadlima (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2533472
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2473097

Hyrimoz (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2542331
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2542366
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2492156

Simlandi (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2523949
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2523965

Simlandi (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2523957

Yuflyma (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2523760
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2535076

Yuflyma (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2523779
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2535084

Abrilada (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 2511061
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2511053

Amgevita (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 2459310
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2459299
Page 1 of 6

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.